Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SINTX Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $8.77 Mil. SINTX Technologies's Total Assets for the quarter that ended in Dec. 2023 was $15.37 Mil.
Therefore, SINTX Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.57.
The historical rank and industry rank for SINTX Technologies's Equity-to-Asset or its related term are showing as below:
SINT'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15 Med: 0.5 Max: 0.85
Current: 0.57
During the past 13 years, the highest Equity to Asset Ratio of SINTX Technologies was 0.85. The lowest was 0.15. And the median was 0.50.
SINT's Equity-to-Asset is ranked worse than 59.77% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs SINT: 0.57
SINTX Technologies Equity-to-Asset Historical Data
The historical data trend for SINTX Technologies's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SINTX Technologies's Equity-to-Asset
For the Medical Devices subindustry, SINTX Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Equity-to-Asset falls into.
SINTX Technologies Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SINTX Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SINTX Technologies Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of SINTX Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
SINTX Technologies (SINTX Technologies) Business Description
SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SINT has been successfully added to your 